A Durham marketer and distributer of generic pharmaceuticals is facing allegations that a diabetes drug it intends to sell infringes on patents owned by Boehringer Ingelheim Pharmaceuticals Inc., a U.S. subsidiary of the German pharmaceutical giant Boehringer Ingelheim International GmbH. In a lawsuit filed Tuesday,…

Read More